Voya Financial, Inc. (VOYA): what the price assumes

In the published model solve dated 2026-Q2, anchored at $97.27, Voya Financial, Inc. (VOYA) is priced for 15.9% return on equity. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-28.

Generated: 2026-09-26 · Source: https://boothcheck.com/report/VOYA

Headline

FieldValue
TickerVOYA
CompanyVoya Financial, Inc.
Current price$97.27/sh
CompositionRetirement 43% / Investment Management 13% / Employee Benefits 43%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisfinancials
Return on equity needed15.9%
Return on equity now12.4%
ROE gap+3.5pp
Price-to-book1.88x

Solve inputs: computed at a 10.3% cost of equity with 4% terminal growth over a 10-year stage, on common book equity (FY2026).

How unusual the bet is: within-range

ReferenceValue
vs own history+1.26σ
cohort percentile (of 78 peers)56
sustained it ~10 years at this level57%
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based value, while earnings-power lands below the price. A value/asset-supported name, not a pure growth bet. No applicable model is available for relative-multiple or growth-DCF.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.17x3expensive
Earnings1.52x1expensive
Relative—0—
Growth—0—

Families that justify the price: Asset Families that call it expensive: Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.9%); the inversion above states its own rate.

Per-Model Detail (n=4)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth——no—
Bank Fair Value (P/TBV)—$62.721.55xyesTBVPS $33.41 × 1.88x (ROE (TTM) 13.0% / CoE 9.3%, g=5.0% (sustainable: 65% retention × ROE, 5% cap; not the terminal-growth assumption))
Relative ValuationRelative——noP/E 11x (static sector reference · 2026-04), scenarios: 9.3x / 11.0x / 12.7x (bear / base = reference held flat / bull), EV/EBITDA 22x
Simple DDMGrowth——no—
Two-Stage DDMGrowth——no—
Simple Excess ReturnAsset$72.551.34xyesBV/sh $51.71, ROE (TTM) 13.0%, ke 9.3%
Two-Stage Excess ReturnAsset$85.231.14xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth——noRev $8.2B, growth 3% (input: historical growth; tapered), Terminal P/S: 0.9x / 1.1x / 1.2x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative——noEPS $5.93, growth 27% (input: historical EPS growth), PEG=0.54 (Undervalued)
Margin TrajectoryGrowth——no—
Earnings Power ValueEarnings——no—
Residual IncomeAsset——no—
Graham NumberAsset$83.061.17xyes√(22.5 × EPS $5.93 × BVPS $51.71) — Graham's conservative floor
EV/EBITDA RelativeRelative——no—
FCF YieldEarnings——no—
SBC-Adj FCF YieldEarnings——no—
Ben Graham FormulaEarnings——noEPS $5.93 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset——no—
P/Sales SectorRelative——no—
PEG Fair ValueRelative——noEPS $5.93 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$64.111.52xyesEPS $5.93 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Economic-Unit Decomposition (Sum Of The Parts)

The issuer is a funded financial business. Debt, interest, and cash flows are operating inputs, so industrial EV, net-debt, WACC, and free-cash-flow lenses do not apply; value the common-equity claim with book, earnings, capital, and payout economics.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
Retirementfinancialequity$3.3b—withheldunresolved standalone equity facts required
Investment Managementfinancialequity$1.0b—withheldunresolved standalone equity facts required
Employee Benefitsfinancialequity$3.3b—withheldunresolved standalone equity facts required

No unit-level total common-equity value is stated. Each financial unit requires supported standalone common equity, normalized earnings, capital adequacy, and payout capacity. Consolidated debt, interest, and cash are operating balances, not an enterprise-to-equity bridge; company-level book, earnings, capital, and payout lenses remain the coherent cross-checks.

Solvency

FieldValue
Share count CAGR (buyback)-4.5%

Deposit/float-funded balance sheet: debt is funding, not corporate leverage, and GAAP operating cash flow follows loan flows. Net-debt, interest-coverage, and cash-burn lenses do not apply. The solvency frame for a financial is regulatory capital and payout capacity (CET1, stress buffer, dividends plus buybacks against earnings).

Bullet Takeaways

Bull Case

Start with what the market is pricing in, then weigh it against the fundamentals, because for Voya the gap is modest and bridgeable. The price assumes a sustained return on equity near 15.6%, against a recent figure around 12.4%. That is a real step up, but the Q1 2026 results show the path. After-tax adjusted operating earnings of $2.26 a share beat consensus by about 7%, GAAP net income rose to $165 million, up 23% year over year, and all three segments contributed: Retirement delivered $209 million of pre-tax operating earnings, Employee Benefits $63 million, and Investment Management $46 million. A diversified fee base firing on all cylinders is exactly what closes the gap between the ROE earned and the ROE assumed.

The business model is the structural attraction. Voya's earnings come largely from administering retirement plans, managing assets, and underwriting workplace benefits, activities that require relatively little balance-sheet capital and generate recurring, fee- and spread-based income on a $1.1 trillion asset base. Retirement client assets reached $780 billion and Investment Management AUM $353 billion, and management expects strong net inflows in both for the year plus 2%-plus organic growth in Investment Management. The Employee Benefits turn is the most encouraging swing: pre-tax earnings there grew 37% year over year on better net underwriting and higher fee revenue, helped by favorable stop-loss loss ratios and group-life mortality, reversing the pressure that had dogged the segment.

The capital story is what makes a fee compounder pay the shareholder. Capital-light businesses throw off cash that does not need to be reinvested in the balance sheet, and Voya returns it: roughly $200 million of excess capital generated in the quarter, $194 million returned through $150 million of buybacks and $44 million of dividends, and a fresh $150 million repurchase authorized for Q2. Buying back stock near book-plus, while the OneAmerica retirement acquisition adds scale, is accretive to both earnings per share and ROE. The analyst consensus is a buy, with an average target right around the current price and RBC recently raising to $91. The bull case is a diversified, capital-light fee franchise with a recovering benefits segment and a disciplined buyback steadily lifting per-share value.

Bear Case

The capital-allocation question is where the bear case sharpens, because the bull thesis leans heavily on buybacks doing the heavy lifting. Voya is returning essentially all of its excess capital, $194 million of a roughly $200 million generation, through repurchases and dividends. That is shareholder-friendly, but it also signals that the company sees limited high-return organic reinvestment, and it means the per-share growth depends on management buying back stock at the right price. At about 1.8 times book, the shares are not cheap on an asset basis, so repurchases here are less obviously accretive than they would be at a discount, and a buyback funded from a fully-distributed capital base leaves little room if earnings stumble.

The earnings quality across the segments is more variable than the consolidated beat suggests. The Employee Benefits recovery was driven by favorable stop-loss loss ratios and beneficial group-life mortality, both of which are inherently volatile insurance variables that can reverse in any given year; a single bad mortality or claims period can swing that 37% growth into a decline. Investment Management earnings ride markets and net flows, so a market drawdown both shrinks the fee-bearing asset base and can trigger outflows at the same time. The price assumes a 15.6% ROE holds steady, but the components that would deliver it are precisely the ones most exposed to claims experience and market levels.

The relative-multiple family in the X-ray lands well below the price, a reminder that on a peer-comparison basis the stock is not screening cheap. The OneAmerica integration adds execution risk, since acquisitions in the retirement business can carry attrition and integration costs that take time to clear. For an investor, the implication is that Voya is fairly valued for a successful continuation of the current trajectory, with the upside dependent on the ROE actually reaching the assumed 15.6% rather than on any discount at entry.

Valuation

A financial is worth the return it earns on its capital, so Voya's price is read off book value rather than an operating multiple. At $90.29 the market pays about 1.8 times book and, on a 10.6% cost of equity with 4% terminal growth, that solves to an assumed sustained return on equity near 15.6%. The reference point is the recent reality of about 12.4%, so the price embeds a moderate improvement in profitability, not a heroic one. The reliability on the solve is reasonable, and the implied step-up is consistent with the operating momentum the latest quarter showed.

The X-ray describes a value-and-asset-supported name rather than a stretched one. That clustering around fair value is the signature of a business the market has already digested: the price broadly reflects book value and current earnings, with the question being whether the assumed ROE materializes.

The honest synthesis is that Voya is fairly priced for the recovery it is delivering. The implied 15.6% ROE is achievable given a recovering Employee Benefits segment, steady retirement and investment-management flows, and a buyback shrinking the share count, but it is above the recent record, so it has to be earned.

Catalysts

The recurring catalyst is the segment earnings trajectory, quarter by quarter. Q1 2026 set the template: adjusted operating EPS of $2.26 beating the $2.11 consensus, GAAP EPS up 23% year over year, with Retirement contributing $209 million, Employee Benefits $63 million (up 37% on better underwriting), and Investment Management $46 million. The key checkpoints are whether Employee Benefits margins hold as stop-loss loss ratios and mortality stay favorable, and whether Retirement and Investment Management deliver the strong net inflows and 2%-plus organic growth management is guiding to.

Capital return is an active catalyst. Voya generated about $200 million of excess capital in the quarter and returned $194 million through $150 million of buybacks and $44 million of dividends, with a new $150 million repurchase set for the second quarter. The pace of buybacks against the share price, and the level of excess capital generation, are direct drivers of per-share value.

Integration and markets frame the rest. The OneAmerica retirement acquisition adds scale to the Retirement segment, so its integration and retention are worth watching. Because Investment Management and the spread-based parts of Retirement ride markets, equity and rate levels are a swing factor for fee-bearing assets and flows. The analyst consensus is a buy with an average target around the current price and RBC recently raising to $91, so a clear continuation of the ROE recovery is what would push targets and sentiment higher.

Peer Cohorts (Per Segment, With Filing Citations)

Retirement (reported)

Investment Management (reported)

Employee Benefits (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

View the full interactive VOYA report on boothcheck